BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng L, Wan TM, Lam CS, Chow AK, Wong SK, Man JH, Li HS, Cheng NS, Pak RC, Cheung AH, Yau TC, Lo OS, Foo DC, Poon JT, Poon RT, Pang RW, Law WL. Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer. PLoS One 2015;10:e0126219. [PMID: 25961724 DOI: 10.1371/journal.pone.0126219] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
2 Ng L, Chow AKM, Man JHW, Yau TCC, Wan TMH, Iyer DN, Kwan VHT, Poon RTP, Pang RWC, Law WL. Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway. BMC Cancer 2018;18:621. [PMID: 29859044 DOI: 10.1186/s12885-018-4326-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
3 Ng L, Wan T, Chow A, Iyer D, Man J, Chen G, Yau TC, Lo O, Foo CC, Poon JT, Poon RT, Pang R, Law WL. Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer. Stem Cells Int 2015;2015:247892. [PMID: 26106421 DOI: 10.1155/2015/247892] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
4 Zubareva EY, Senchukova MA. Prognostic and predictive significance of osteopontin in malignant neoplasms. Usp mol onkol 2021;8:23-8. [DOI: 10.17650/2313-805x-2021-8-2-23-28] [Reference Citation Analysis]
5 Butti R, Nimma R, Kundu G, Bulbule A, Kumar TVS, Gunasekaran VP, Tomar D, Kumar D, Mane A, Gill SS, Patil T, Weber GF, Kundu GC. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression. Oncogene 2021;40:2002-17. [PMID: 33603163 DOI: 10.1038/s41388-021-01663-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Žlajpah M, Boštjančič E, Zidar N. (Epi)genetic regulation of osteopontin in colorectal cancerogenesis. Epigenomics 2020;12:1389-403. [PMID: 32921164 DOI: 10.2217/epi-2020-0032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kong W, Yin G, Zheng S, Liu X, Zhu A, Yu P, Zhang J, Shan Y, Ying R, Jin H. Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer. Genes Dis 2022;9:1269-80. [PMID: 35873034 DOI: 10.1016/j.gendis.2021.07.006] [Reference Citation Analysis]
8 Wei R, Wong JPC, Kwok HF. Osteopontin -- a promising biomarker for cancer therapy. J Cancer 2017;8:2173-83. [PMID: 28819419 DOI: 10.7150/jca.20480] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 12.4] [Reference Citation Analysis]
9 Liu F, Bai C, Guo Z. The prognostic value of osteopontin in limited-stage small cell lung cancer patients and its mechanism. Oncotarget 2017;8:70084-96. [PMID: 29050263 DOI: 10.18632/oncotarget.19589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Nazarizadeh A, Alizadeh-Fanalou S, Hosseini A, Mirzaei A, Salimi V, Keshipour H, Safizadeh B, Jamshidi K, Bahrabadi M, Tavakoli-Yaraki M. Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors. J Bone Oncol 2021;29:100377. [PMID: 34235049 DOI: 10.1016/j.jbo.2021.100377] [Reference Citation Analysis]
11 Whittle MC, Hingorani SR. Runx3 and Cell Fate Decisions in Pancreas Cancer. Adv Exp Med Biol 2017;962:333-52. [PMID: 28299667 DOI: 10.1007/978-981-10-3233-2_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Kocael A, Vatankulu B, Şimşek O, Cengiz M, Kemik A, Kocael P, Halaç M, Sönmezoğlu K, Ulualp K. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer. Tumour Biol 2016;37:3871-7. [PMID: 26476536 DOI: 10.1007/s13277-015-4218-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Hao C, Cui Y, Owen S, Li W, Cheng S, Jiang WG. Human osteopontin: Potential clinical applications in cancer (Review). Int J Mol Med 2017;39:1327-37. [PMID: 28440483 DOI: 10.3892/ijmm.2017.2964] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
14 Singh N, Mishra A, Sahu DK, Jain M, Shyam H, Tripathi RK, Shankar P, Kumar A, Alam N, Jaiswal R, Kumar S. Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma. Cancer Manag Res 2020;12:11973-88. [PMID: 33244273 DOI: 10.2147/CMAR.S279974] [Reference Citation Analysis]
15 Huang C, Liu H, Gong X, Wen B, Chen D, Liu J, Hu F. Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis. Mol Med Rep 2016;14:2555-65. [PMID: 27484148 DOI: 10.3892/mmr.2016.5584] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Leung DT, Lim PL, Cheung TH, Wong RR, Yim SF, Ng MH, Tam FC, Chung TK, Wong YF. Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients. PLoS One 2016;11:e0160412. [PMID: 27494141 DOI: 10.1371/journal.pone.0160412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Giles AJ, Chien CD, Reid CM, Fry TJ, Park DM, Kaplan RN, Gilbert MR. The functional interplay between systemic cancer and the hematopoietic stem cell niche. Pharmacol Ther 2016;168:53-60. [PMID: 27595927 DOI: 10.1016/j.pharmthera.2016.09.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
18 Melve GK, Ersvaer E, Akkök ÇA, Ahmed AB, Kristoffersen EK, Hervig T, Bruserud Ø. Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor. Int J Mol Sci 2016;17:E1158. [PMID: 27447610 DOI: 10.3390/ijms17071158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Castoldi DF, Malafaia O, Santos-Neto PHD, Postiglioni TV, Vasconcelos C, Bremer FP, Czeczko LEA, Gasser M, Waaga-Gasser AM, Ribas CAPM. IS THERE A CLINICAL PATHOLOGICAL CORRELATION OF COLORECTAL ADENOCARCINOMA WITH THE IMMUNOHISTOCHEMICAL EXPRESSION OF OPN AND ABCB5? Arq Bras Cir Dig 2021;33:e1569. [PMID: 33759959 DOI: 10.1590/0102-672020200004e1569] [Reference Citation Analysis]
20 Lamort AS, Giopanou I, Psallidas I, Stathopoulos GT. Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight. Cells 2019;8:E815. [PMID: 31382483 DOI: 10.3390/cells8080815] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
21 Chang S, Huang J, Niu H, Wang J, Si Y, Bai Z, Cheng S, Ding W. Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment. Cancer Cell Int 2020;20:452. [PMID: 32944000 DOI: 10.1186/s12935-020-01541-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Huang J, Chang S, Lu Y, Wang J, Si Y, Zhang L, Cheng S, Jiang WG. Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells. Cancer Cell Int 2019;19:306. [PMID: 31832019 DOI: 10.1186/s12935-019-1033-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Kothari AN, Arffa ML, Chang V, Blackwell RH, Syn WK, Zhang J, Mi Z, Kuo PC. Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition. J Clin Med 2016;5:E39. [PMID: 27023622 DOI: 10.3390/jcm5040039] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
24 Zhang J, Yang G, Zhu Y, Peng X, Li T, Liu L. Relationship of Cx43 regulation of vascular permeability to osteopontin-tight junction protein pathway after sepsis in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2018;314:R1-R11. [DOI: 10.1152/ajpregu.00443.2016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]